Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
8,279.60
7,234.50
6,702.90
6,281.73
6,130.16
6,098.54
5,975.79
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
8,279.60
7,234.50
6,702.90
6,281.73
6,130.16
6,098.54
5,975.79
Raw Material Cost
2,320.30
1,985.30
1,821.30
1,666.41
1,348.70
1,348.75
1,438.02
Purchase of Finished goods
313.10
297.10
241.20
252.22
201.62
167.63
154.62
(Increase) / Decrease In Stocks
10.90
34.60
78.20
-40.70
-62.32
19.63
-137.46
Employee Cost
2,700.60
2,267.90
2,216.00
2,166.02
2,043.39
1,922.88
1,843.22
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
112.21
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
1,674.90
1,475.90
1,445.40
1,461.53
1,442.44
1,243.18
1,017.23
Total Expenditure (Excl Depreciation)
7,019.80
6,060.80
5,802.10
5,505.48
4,973.83
4,702.07
4,427.84
Operating Profit (PBDIT) excl Other Income
1,259.80
1,173.70
900.80
776.25
1,156.33
1,396.47
1,547.95
Other Income
66.00
56.80
68.70
38.33
11.29
17.64
37.41
Operating Profit (PBDIT)
1,325.80
1,230.50
969.50
814.58
1,167.62
1,414.11
1,585.36
Interest
211.80
240.30
272.30
188.20
145.49
184.10
199.71
Exceptional Items
-59.20
359.50
-168.90
-56.82
0.00
-21.23
-32.94
Gross Profit (PBDT)
1,054.80
1,349.70
528.30
569.56
1,022.13
1,208.78
1,352.71
Depreciation
440.40
368.60
381.90
554.03
381.70
348.95
339.84
Profit Before Tax
614.40
981.10
146.40
15.53
640.43
859.83
1,012.87
Tax
216.60
144.30
97.80
92.66
217.43
297.22
335.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
397.80
836.80
48.60
-77.13
423.00
562.61
677.77
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
261.75
220.47
Net Profit
397.80
836.80
48.60
-77.13
423.00
824.36
898.24
Share in Profit of Associates
-0.30
-0.50
24.10
12.25
-9.98
11.25
0.00
Minority Interest
1.00
3.10
4.40
3.90
0.92
0.26
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
398.50
839.40
77.10
-60.98
413.94
835.87
898.24
Equity Capital
15.80
15.80
15.80
15.91
15.92
15.92
15.93
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
7,077.00
6,239.10
5,418.10
5,383.37
5,302.64
4,725.57
5,587.95
Earnings per share (EPS)
25.22
53.13
4.88
-3.83
26.0
52.5
48.93
Diluted Earnings per share
25.08
52.85
4.86
-3.83
26.0
52.48
56.39
Operating Profit Margin (Excl OI)
15.32%
16.32%
13.56%
12.48%
19.08%
23.42%
26.49%
Gross Profit Margin
12.82%
18.77%
7.95%
9.16%
16.87%
20.27%
23.15%
PAT Margin
4.83%
11.63%
1.09%
-1.04%
6.82%
9.62%
11.6%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 14.45% vs 7.93% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is -52.53% vs 988.72% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 7.34% vs 30.30% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -11.86% vs -11.75% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of Jubilant Pharmo With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
8,279.60
4,078.30
4,201.30
103.02%
Other Operating Income
0.00
0.00
0.00
Total Operating income
8,279.60
4,078.30
4,201.30
103.02%
Raw Material Cost
2,320.30
593.50
1,726.80
290.95%
Purchase of Finished goods
313.10
203.20
109.90
54.08%
(Increase) / Decrease In Stocks
10.90
-106.20
117.10
110.26%
Employee Cost
2,700.60
687.20
2,013.40
292.99%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
1,674.90
1,264.10
410.80
32.50%
Total Expenditure (Excl Depreciation)
7,019.80
2,641.80
4,378.00
165.72%
Operating Profit (PBDIT) excl Other Income
1,259.80
1,436.50
-176.70
-12.30%
Other Income
66.00
297.60
-231.60
-77.82%
Operating Profit (PBDIT)
1,325.80
1,734.10
-408.30
-23.55%
Interest
211.80
36.70
175.10
477.11%
Exceptional Items
-59.20
0.00
-59.20
Gross Profit (PBDT)
1,054.80
1,697.40
-642.60
-37.86%
Depreciation
440.40
206.60
233.80
113.17%
Profit Before Tax
614.40
1,490.80
-876.40
-58.79%
Tax
216.60
118.90
97.70
82.17%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
397.80
1,371.90
-974.10
-71.00%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
397.80
1,371.90
-974.10
-71.00%
Share in Profit of Associates
-0.30
46.60
-46.90
-100.64%
Minority Interest
1.00
0.00
1.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
398.50
1,418.50
-1,020.00
-71.91%
Equity Capital
15.80
35.80
-20.00
-55.87%
Face Value
1.00
2.00
0.00
Reserves
7,077.00
9,185.30
-2,108.30
-22.95%
Earnings per share (EPS)
25.22
79.25
-54.03
-68.18%
Diluted Earnings per share
25.08
79.20
-54.12
-68.33%
Operating Profit Margin (Excl OI)
15.32%
35.22%
0.00
-19.90%
Gross Profit Margin
12.82%
41.62%
0.00
-28.80%
PAT Margin
4.83%
33.64%
0.00
-28.81%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 8,279.60 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 14.45% vs 7.93% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 398.50 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -52.53% vs 988.72% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,259.80 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 7.34% vs 30.30% in Mar 2025
Annual - Interest
Interest 211.80 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -11.86% vs -11.75% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.32%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
